Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Yamanouchi describes potent and selective steroid 17,20 lyase inhibitor

April 22, 1997

BASF selects dual D4/5-HT2 antagonist for clinical development

April 22, 1997

MS&D designs potent and selective dopamine D4 antagonist

April 21, 1997

New opioid analgesic from Glaxo Wellcome

April 21, 1997

Warner-Lambert describes new dopamine D4 antagonists

April 18, 1997

New MMP inhibitor disclosed by Agouron

April 18, 1997

Pfizer characterizes new antipsychotic agent

April 17, 1997

New cell adhesion inhibitor from Biogen

April 17, 1997

Telomerase detection for bladder/prostatic cancer highlighted at AUA meeting

April 17, 1997

Dual TxA2/LT receptor antagonist selected for development by Yamanouchi

April 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...